1. Home
  2. NECB vs SLN Comparison

NECB vs SLN Comparison

Compare NECB & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NorthEast Community Bancorp Inc.

NECB

NorthEast Community Bancorp Inc.

HOLD

Current Price

$23.06

Market Cap

282.4M

Sector

Finance

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$6.14

Market Cap

318.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NECB
SLN
Founded
1934
1994
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.4M
318.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NECB
SLN
Price
$23.06
$6.14
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$39.67
AVG Volume (30 Days)
48.7K
309.7K
Earning Date
01-28-2026
11-06-2025
Dividend Yield
4.37%
N/A
EPS Growth
N/A
N/A
EPS
3.21
N/A
Revenue
$102,569,000.00
$25,830,000.00
Revenue This Year
$1.90
N/A
Revenue Next Year
$6.93
N/A
P/E Ratio
$7.12
N/A
Revenue Growth
N/A
40.39
52 Week Low
$19.27
$1.97
52 Week High
$25.93
$8.08

Technical Indicators

Market Signals
Indicator
NECB
SLN
Relative Strength Index (RSI) 57.66 44.28
Support Level $22.81 $6.11
Resistance Level $24.13 $6.59
Average True Range (ATR) 0.63 0.45
MACD -0.07 -0.03
Stochastic Oscillator 55.85 12.87

Price Performance

Historical Comparison
NECB
SLN

About NECB NorthEast Community Bancorp Inc.

NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: